Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDIV × Salicylates × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

ethyl pyruvate 1 compound W 1 Salicylates 1 Bimatoprost 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01712295 2012-10-23

17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

Grossman, Michael, D.P.M.

Phase 4 Unknown

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡